EMPLOYMENT AGREEMENTEmployment Agreement • May 1st, 2017 • Motif Bio PLC • Pharmaceutical preparations
This Employment Agreement (this “Agreement”) is effective as of January 16, 2017 (the “Effective Date”), and is entered into by and between Motif BioSciences Inc. (the “Company”), and Robert Dickey IV (“Employee”) (collectively with the Company, the “Parties”; each of the Parties referred to individually as a “Party”).
2,438,491 AMERICAN DEPOSITARY SHARES, EACH REPRESENTING 20 ORDINARY SHARES, £0.01 PAR VALUE, AND WARRANTS TO PURCHASE 1,219,246 AMERICAN DEPOSITARY SHARES MOTIF BIO PLC UNDERWRITING AGREEMENTUnderwriting Agreement • May 1st, 2017 • Motif Bio PLC • Pharmaceutical preparations • New York
This letter is delivered to you pursuant to the Underwriting Agreement (the “Underwriting Agreement”) to be entered into by the Company, as issuer, and Rodman & Renshaw, a unit of H.C. Wainwright & Co., LLC, as representative (the “Representative”) of certain underwriters (the “Underwriters”) to be named therein. Upon the terms and subject to the conditions of the Underwriting Agreement, the Underwriters intend to effect a public offering of American Depositary Shares (“ADSs”), each of which represents 20 Ordinary Shares, of one penny each in capital, of the Company (the “Ordinary Shares”), and warrants (“Warrants”) to purchase ADSs, as described in and contemplated by the registration statement of the Company on Form F-1, File No. 333-212491 (the “Registration Statement”), as subsequently amended (the “Offering”).
INDEPENDENT CONTRACTOR AGREEMENTIndependent Contractor Agreement • May 1st, 2017 • Motif Bio PLC • Pharmaceutical preparations • New York
This Independent Contractor Agreement (the “Agreement”) is entered into on this 7th day of April, 2017, between Motif BioSciences Inc. (“Motif”), and Jonathan E. Gold (“Consultant”), each a “Party” and, collectively, the “Parties.”
CONFIDENTIAL SEPARATION AGREEMENT AND RELEASESeparation Agreement • May 1st, 2017 • Motif Bio PLC • Pharmaceutical preparations • New York
THIS CONFIDENTIAL SEPARATION AGREEMENT AND RELEASE (the “Agreement”) is made and entered into by and between Pete A. Meyers (“Meyers”) and Motif BioSciences Inc., (the “Company”) (collectively, the “Parties”)
CONSULTING AGREEMENT Effective Date: January 16, 2017Consulting Agreement • May 1st, 2017 • Motif Bio PLC • Pharmaceutical preparations • Delaware
THIS CONSULTING AGREEMENT (this “Agreement”) is entered into by and between Motif Biosciences, Inc., a Delaware corporation (the “Company”), and Pete A. Meyers, an individual (“Consultant”), as of the date set forth above (the “Effective Date”).
